Analystreport

Akero Therapeutics (NASDAQ:AKRO) had its "peer perform" rating reaffirmed by analysts at Wolfe Research.

Akero Therapeutics, Inc.  (AKRO) 
Last akero therapeutics, inc. earnings: 3/16 07:30 am Check Earnings Report